Full Text
The Full Text of this article is available as a PDF (345.5 KB).
. 1997 Jan 18;314(7075):180–181. doi: 10.1136/bmj.314.7075.180
Severe persistent visual field constriction associated with vigabatrin.
1Department of Ophthalmology, Leicester Royal Infirmary.
PMCID: PMC2125673 PMID: 9022432
See letter "Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing." on page 1694a.
See letter "Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions." on page 1693b.
See letter "Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies." on page 1694c.
See letter "Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist." on page 1694b.
See letter "Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent." on page 1693c.
See letter "Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin." in volume 316 on page 233a.
See letter "Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients." in volume 316 on page 232b.